Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Fischinger

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Journal of Virology|August 1, 1990
Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzeesP L Nara, L Smit, N Dunlop, et al.
Virology|May 1, 1984
Properties of mouse leukemia viruses. XIX. Effective antibody therapy of AKR leukemia occurs independently of virus neutralization and produces long-term changes in the virus status of the thymusK J Weinhold, G Hüper, T J Matthews, et al.
Journal of Virology|October 1, 1987
Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated virusesP L Nara, W G Robey, L O Arthur, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1988
Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120J R Rusche, K Javaherian, C McDanal, et al.
Archives of Virology|January 1, 1987
Simultaneous isolation of simian foamy virus and HTLV-III/LAV from chimpanzee lymphocytes following HTLV-III or LAV inoculationP L Nara, W G Robey, L O Arthur, et al.
Journal of Virology|August 1, 1988
Purified envelope glycoproteins from human immunodeficiency virus type 1 variants induce individual, type-specific neutralizing antibodiesP L Nara, W G Robey, S W Pyle, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1987
Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptideK B Cease, H Margalit, J L Cornette, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1986
Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibodyW G Robey, L O Arthur, T J Matthews, et al.
Vaccine|October 1, 1989
Immune response to immunostimulatory complexes (ISCOMs) prepared from human immunodeficiency virus type 1 (HIV-1) or the HIV-1 external envelope glycoprotein (gp120)S W Pyle, B Morein, J W Bess, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Journal of Virology|August 1, 1990
Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzeesP L Nara, L Smit, N Dunlop, et al.
Virology|May 1, 1984
Properties of mouse leukemia viruses. XIX. Effective antibody therapy of AKR leukemia occurs independently of virus neutralization and produces long-term changes in the virus status of the thymusK J Weinhold, G Hüper, T J Matthews, et al.
Journal of Virology|October 1, 1987
Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated virusesP L Nara, W G Robey, L O Arthur, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1988
Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120J R Rusche, K Javaherian, C McDanal, et al.
Archives of Virology|January 1, 1987
Simultaneous isolation of simian foamy virus and HTLV-III/LAV from chimpanzee lymphocytes following HTLV-III or LAV inoculationP L Nara, W G Robey, L O Arthur, et al.
Journal of Virology|August 1, 1988
Purified envelope glycoproteins from human immunodeficiency virus type 1 variants induce individual, type-specific neutralizing antibodiesP L Nara, W G Robey, S W Pyle, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1987
Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptideK B Cease, H Margalit, J L Cornette, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1986
Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibodyW G Robey, L O Arthur, T J Matthews, et al.
Vaccine|October 1, 1989
Immune response to immunostimulatory complexes (ISCOMs) prepared from human immunodeficiency virus type 1 (HIV-1) or the HIV-1 external envelope glycoprotein (gp120)S W Pyle, B Morein, J W Bess, et al.
Pageof 7